Skip to main content
. 2021 Nov 17;12:766391. doi: 10.3389/fimmu.2021.766391

Figure 2.

Figure 2

All CitH3 may be a promising prognostic biomarker in septic AP patients. AP patients were subgrouped into survival and death groups (A) or ICU (cases admitted into ICU) and non-ICU (cases not admitted into ICU) groups (C). Concentration of CitH3 was measured by ELISA. Levels of CitH3 were increased significantly in the death group and ICU group compared with those in survival group and non-ICU group, respectively. Receiver operating characteristic curve analysis of CitH3 to distinguish survival and death cases (B) and cases admitted or not into ICU (D). The detailed information of receiver operating characteristic curve analysis is presented in the table (E). * p < 0.05.